Oh, H. Et Al. 2022. Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions. JOURNAL OF CELLULAR PHYSIOLOGY , vol.237, no.11 , 4226-4237.

Oh, H., Park, S. Y., Cho, W., HASSIBELNABY, A. M. A., HACIMÜFTÜOĞLU, A., Kwon, C. H., ... Jeong, J. H.(2022). Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions. JOURNAL OF CELLULAR PHYSIOLOGY , vol.237, no.11, 4226-4237.

Oh, Heeseung Et Al. "Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions," JOURNAL OF CELLULAR PHYSIOLOGY , vol.237, no.11, 4226-4237, 2022

Oh, Heeseung Et Al. "Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions." JOURNAL OF CELLULAR PHYSIOLOGY , vol.237, no.11, pp.4226-4237, 2022

Oh, H. Et Al. (2022) . "Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions." JOURNAL OF CELLULAR PHYSIOLOGY , vol.237, no.11, pp.4226-4237.

@article{article, author={Heeseung Oh Et Al. }, title={Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions}, journal={JOURNAL OF CELLULAR PHYSIOLOGY}, year=2022, pages={4226-4237} }